VisionCare Ophthalmic Technologies, Inc., a Saratoga, CA-based developer of advanced visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD).
VisionCare Ophthalmic Technologies (VisionCare) is a privately held specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders.
Our lead product, the Implantable Miniature Telescope (by Dr. Isaac Lipshitz), is the first FDA-approved implantable medical device demonstrated to improve vision and quality of life in individuals with the most advanced, irreversible form of age-related macular degeneration (AMD) – End-Stage AMD. End-Stage AMD is the leading cause of blindness in older Americans.
The telescope implant is integral to the CentraSight™ treatment program which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care.
Our goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services.
Funding Rounds (8) - $95.2MUpdate
|Date||Amount / Round||Valuation||Lead Investor||Investors|
|Dec, 2014||undisclosed amount / Venture||—||—||1|
|Sep, 2013||$15M / Debt Financing||—||—||1|
|Jan, 2012||$4M / Series E||—||—||0|
|Jan, 2011||$31M / Series E||—||Saints Capital||6|
|Jan, 2005||$20M / Series D||—||Boston Scientific||5|
|Nov, 2003||$12.4M / Series C||—||—||4|
|Jul, 2002||$6.8M / Series C||—||—||4|
|Dec, 1999||$6M / Series A||—||—||4|
Current Team (8)Update
|Mar 8, 2016||PRNewswire All - Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026|
|Feb 17, 2015||Fierce Medical Devices - Swiss developers debut telescopic contact lens triggered by blinking|
|Sep 17, 2013||Yahoo Finance - VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration|
|Jan 23, 2012||visioncareinc.net - VisionCare Ophthalmic Technologies raises 4000000 in venture round|
|Jan 11, 2011||FinSMEs - FinSMEs|
|Jan 10, 2011||Xconomy - VisionCare Ophthalmic Technologies Secures $31,000,000 Series E Financing|
|Jul 8, 2010||Engadget - Telescopic eye implant approved by the FDA|
|Sep 30, 2009||Xconomy - VisionCare Ophthalmic Technologies Lands New Financing|
21 Yagia Kapayim St.
Petah Tiqva, 4913020
14395 Saratoga Ave
Saratoga, CA 95070